Merck
CN
Search Within
文件类型

201-757-1

应用筛选条件
关键词:'201-757-1'
显示 1-15 共 15 条结果 关于 "201-757-1" 范围 技术文档
Quality Control Ranges: MILLIPLEX® MAP Human Immuno-Oncology Checkpoint Protein Panel 2
Control 1 3018 - 6269 pg/mL E-Cadherin Control 1 6092 - 12653 pg/ml Control 2 10735 - 23602 pg/mL Control 2 18187 - 37772 pg/ml
Quality Control Range Sheet- B6062-101 and B6062-201
/mL Control 2 364 – 757 pg/mL Control 2 17218 – 35760 pg/mL BAFF Control 1 409 – 850 pg/mL I-309 Control 1 38 –
Product Information Sheet - T6381
utilizing gas chromatography with mass selective detection. J. Chromatogr. B Biomed. Sci. Appl., 757(1), 161-172 (2001). 8. Destaillats, H., et al., Ambient air measurement of acrolein and other
Data Sheet - T8690
Invest., 98, 2469-2477 (1996). 10. Tagaya, Y., et al., EMBO J., 8, 757-764 (1989). 11. Ericson, M., et al., Lymph. Cyto. Res., 11, 201-207 (1992). 12. Wakasugi, N., et al., Proc. Natl. Acad.Sci. U.
XP725 Antibody Number-Lot Number 071M4826
705 706 707 708 729 730 731 732 753 754 755 756 8.4 685 686 687 688 709 710 711 712 733 734 735 736 757 758 759 760 8.5 689 690 691 692 713 714 715 716 737 738 739 740
Research Article: MCP-1, KC-like and IL-8 as critical mediators of
10.1371/journal.pone.0190474 in MCP-1 levels have been previously found between control dogs (118 pg/mL), survivors (431 pg/mL) and non-survivors (757 pg/mL) in the case of B.canis- induced babesiosis
XP725 Antibody List Lot 129K4831
063940.1 y y n/d 716 TOM22 T6319 56993 TOMM22 M NP_064628.1 y n/d n/d 756 VGLUT 1 V0389 57030 SLC17A7 P NP_064705.1 y n/d n/d 757 VGLUT 2 V2639 57084 SLC17A6 P NP_065079.1 n/d n/d y 469 MTA3L M0819 57504 MTA3
XP725 Antibody List Lot 129K4830
063940.1 y y n/d 716 TOM22 T6319 56993 TOMM22 M NP_064628.1 y n/d n/d 756 VGLUT 1 V0389 57030 SLC17A7 P NP_064705.1 y n/d n/d 757 VGLUT 2 V2639 57084 SLC17A6 P NP_065079.1 n/d n/d y 469 MTA3L M0819 57504 MTA3
XP725 Antibody List Lot 089K4791
063940.1 y y n/d 716 TOM22 T6319 56993 TOMM22 M NP_064628.1 y n/d n/d 756 VGLUT 1 V0389 57030 SLC17A7 P NP_064705.1 y n/d n/d 757 VGLUT 2 V2639 57084 SLC17A6 P NP_065079.1 n/d n/d y 469 MTA3L M0819 57504 MTA3
List of Antibodies
C7339 M y y n/d 199 Cyclin D3 C7214 M y y y 200 Cyclin H C5351 P y n/d n/d 201 Cystatin A C3095 M y n/d n/d 202 Cytohesin-1 C8979 M y n/d n/d 203 Cytokeratin peptide 4
XP725 Antibody List
.1 M y y y 200 Cyclin H C5351 902 CCNH NP_001230.1 P y n/d n/d 201 Cystatin A C3095 1475 CSTA NP_005204.1 M y n/d n/d 202 Cytohesin-1 C8979 9267 PSCD1 NP_059430.2 M y n/d n/d 203 Cytokeratin
XP725 Antibody List 013M4793
.1 M y y y 200 Cyclin H C5351 902 CCNH NP_001230.1 P y n/d n/d 201 Cystatin A C3095 1475 CSTA NP_005204.1 M y n/d n/d 202 Cytohesin-1 C8979 9267 PSCD1 NP_059430.2 M y n/d n/d 203 Cytokeratin
Halal Certificate
FG W217514 B15184 HC-23SIWK54 756. ISOBUTYL ALCOHOL 99%, FCC, FG W217905 A70506 HC-23SIIX23 757. ISOBUTYL ALCOHOL, NATURAL W217913 C36274 HC-23SIZJ90 758. ISOBUTYL BUTYRATE 98%, FCC, FG W218707
Halal Certificate
FG W217514 B15184 HC-22SIZJ75 756. ISOBUTYL ALCOHOL 99%, FCC, FG W217905 A70506 HC-22SI2W44 757. ISOBUTYL ALCOHOL, NATURAL W217913 C36274 HC-22SIA812 758. ISOBUTYL BUTYRATE 98%, FCC, FG W218707
XP725 Worksheet for Lot Number 071M4826
p 198 2 1 1 6 Caldesmon C6542 199 2 1 1 7 Calmodulin C7055 200 2 1 1 8 Calmodulin C7055 201 2 1 2 1 Calnexin C4731 202 2 1 2 2 Calnexin C4731 203 2 1 2 3 Calponin C2687 204 2